Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial

Phytomedicine

Volumn 18, Issue 8-9, 2011, Pages 739-742

  Singer, A ^a   Schmidt, M ^a   Hauke, W ^a   Stade, K ^b  

^a Pierrel Research Onco Immunology GmbH   (Germany)

^b Analyze and Realize GmbH   (Germany)

Author keywords

Citalopram; Hypericum extract; Moderate depression; Recurrence; Relapse; St. John's Wort

Indexed keywords

CITALOPRAM; HYPERICUM PERFORATUM EXTRACT; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HAMILTON SCALE; HUMAN; HYPERICUM PERFORATUM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; YOUNG ADULT;

HYPERICUM; HYPERICUM PERFORATUM;

EID: 79958105002     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.02.016     Document Type: Article

References (33)

1. American Psychiatric Association (APA), 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed. APA, Washington, DC, pp. 339-345.
2. Blier, P., Keller, M.B., Pollack, M.H., Thase, M.E., Zajecka, J.M., Dunner, D.L., 2007. Preventing recurrent depression: long-term treatment for major depressive disorder. J. Clin. Psychiatry 68, e06.
3. Doris, A., Ebmeier, K., Shajahan, P., 1999. Depressive illness. Lancet 354, 1369-1375. (Pubitemid 29481640)
4. EMEA, 2002. Note for guidance on clinical investigation of medicinal products in the treatment of depression. CPMP/EWP/518/97 rev1.
5. Frank, E., Novick, D., Kupfer, D.J., 2005. Antidepressants and psychotherapy: a clinical research review. Dialogues Clin. Neurosci. 7, 263-272.
6. Gastpar, M., Singer, A., Zeller, K., 2006. Comparative efficacy and safety of a once-daily dosage of Hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study. Pharmacopsychiatry 39, 66-75.
7. Hamilton, M., 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56-62.
8. Hansen, R.A., Gartlehner, G., Lohr, K.N., Gaynes, B.N., Carey, T.S., 2005. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann. Intern. Med. 143, 415-426.
9. HMPC Community herbal monograph on Hypericum perforatum L., Herba (well-established medicinal use), 2009. EMA/HMPC/101304/2008. Available from: http://www.ema.europa.eu (12.11.09).
10. Kasper, S., 2000. Hypericum perforatum - a review of clinical studies. Pharmacopsychiatry 34, 51-55.
11. Kasper, S., Volz, H.P., Moller, H.J., Dienel, A., Kieser, M., 2008. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression - a double-blind, randomized, placebo controlled long-term trial. Eur. Neuropsychopharmacol. 18, 803-813.
12. Keller, M.B., 2006. Long-term treatment of patients with recurrent unipolar major depression: evidence to clinical practice. CNS Spectr. 11, 4-5. (Pubitemid 46012528)
13. Khawam, E.A., Laurencic, G., Malone Jr., D.A., 2006. Side effects of antidepressants: an overview. Clev. Clin. J. Med. 73, 356-361, 351-353.
14. Kommission EMonographie Hyperici herba (Johanniskraut) (in German), 1984. Bundesanzeiger 228, 05.12.1984.
15. Krebs, E.E., Gaynes, B.N., Gartlehner, G., Hansen, R.A., Thieda, P., Morgan, L.C., DeVeaugh-Geiss, A., Lohr, K.N., 2008. Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and meta analysis. Psychosomatics 49, 191-198. (Pubitemid 351668719)
16. Linde, K., Berner, M., Egger, M., Mulrow, C., 2005. St John's Wort for depression: meta-analysis of randomised controlled trials. Br. J. Psychiatry 186, 99-107. (Pubitemid 40193777)
17. Linde, K., Mulrow, C.D., Berner, M., Egger, M., 2008. St John's Wort for Depression (Review). The Cochrane Library.
18. Mulrow, C.D., Williams Jr., J.W., Trivedi, M., Chiquette, E., Aguilar, C., Cornell, J.E., Badgett, R., Noël, P.H., Lawrence, V., Lee, S., Luther, M., Ramirez, G., Richardson, W.S., Stamm, K., 1998. Treatment of depression - newer pharmacotherapies. Psychopharmacol. Bull. 34, 409-795.
19. Nierenberg, A.A., Petersen, T.J., Alpert, J.E., 2003. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. J. Clin. Psychiatry 64 (Suppl. 15), 13-17.
20. Norman, T.R., Burrows, G.D., 2007. Emerging treatments for major depression. Expert Rev. Neurother. 7, 203-213.
21. Parker, G., 2005. Beyond major depression. Psychol. Med. 35, 467-474.
22. Paykel, E.S., 2006. Depression: major problem for public health. Epidemiol. Psichiatr. Soc. 15, 4-10.
23. Petersen, T.J., 2006. Enhancing the efficacy of antidepressants with psychotherapy. J. Psychopharmacol. 20, 19-28. (Pubitemid 44605929)
24. Pharmacopoea Europaea, (2011). St. John's Wort dry extract quantified. Pharmacopoea Europea. 7.2, EDQM (Ed.), Strasbourg, France.
25. Pincus, H.A., Pettit, A.R., 2001. The societal costs of chronic major depression. J. Clin. Psychiatry 62 (Suppl 6), 5-9.
26. Segal, Z.V., Pearson, J.L., Thase, M.E., 2003. Challenges in preventing relapse in major depression. Report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression. J. Affect. Disord. 77, 97-108.
27. Storosum, J.G., van Zwieten, B.J., Vermeulen, H.D., Wohlfarth, T., van den Brink, W., 2001. Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issues. Eur. Psychiatry 16, 327-335. (Pubitemid 32928946)
28. Thase, M.E., 1990. Relapse and recurrence in unipolar major depression: short-term and long-term approaches. J. Clin. Psychiatry 51 (Suppl.), 51-57, discussion 58-59.
29. Thase, M.E., 2006. Preventing relapse and recurrence of depression: a brief review of therapeutic options. CNS Spectr. 11, 12-21. (Pubitemid 46012530)
30. Volz, H.P., 1997. Controlled clinical trials of Hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 30, 72-76.
31. Werneke, U., Northey, S., Bhugra, D., 2006. Antidepressants and sexual dysfunction. Acta Psychiatr. Scand. 114, 384-397.
32. WHO, 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva.
33. WHO, 2001. The World Health Report: Mental Health: New Understandings, New Hope. Available from: http://www.who.int/whr/.